Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

The University of Cincinnati Cancer

2 abstracts

Abstract
GOG3069: Phase 2 study of alpelisib and fulvestrant for PIK3CA-mutated estrogen receptor (ER)-positive endometrioid endometrial cancers.
Org: Kettering Health Cancer Center, St. Vincent Hospital and Health Care Centers, Legacy Good Samaritan Medical Center, University of Wisconsin-Madison School of Medicine and Public Health, The University of Cincinnati Cancer,
Abstract
Predictors of long-term progression-free survival (PFS) in niraparib-treated patients (pts) from the PRIMA/ENGOT-OV26/GOG-3012 study.
Org: Medical University of South Carolina Hollings Cancer Center, Institut Català d’Oncologia L’Hospitalet de Llobregat, Hospital Duran i Reynals, IDIBELL, Grupo Español de Investigación en Cáncer de Ovario (GEICO),